Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Buss

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Australian Health Review : a Publication of the Australian Hospital Association|August 11, 2001
From efficacy to effectiveness: managing organisational change to improve health services for young people with deliberate self harm behaviourM J Tobin, A R Clarke, R Buss, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 25, 2006
Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALSThomas W Gould, Robert R Buss, Sharon Vinsant, et al.
American Journal of Physiology. Cell Physiology|January 21, 2011
Small GTPase Rab11b regulates degradation of surface membrane L-type Cav1.2 channelsJabe M Best, Jason D Foell, Courtney R Buss, et al.
Genetics|March 17, 2004
Recombination within a nucleotide-binding-site/leucine-rich-repeat gene cluster produces new variants conditioning resistance to soybean mosaic virus in soybeansA J Hayes, S C Jeong, M A Gore, et al.
Crop Science|January 5, 2002
Genetic and Sequence Analysis of Markers Tightly Linked to the Soybean mosaic virus Resistance Gene, Rsv3S. C. Jeong, S. Kristipati, A. J. Hayes, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 29, 2006
Neuromuscular development in the absence of programmed cell death: phenotypic alteration of motoneurons and muscleRobert R Buss, Thomas W Gould, Jianjun Ma, et al.
ESMO Open|June 11, 2026
First-line ET plus palbociclib versus standard mono-chemotherapy in high-risk HR-positive/HER2-negative metastatic breast cancer and indication for chemotherapy: primary results from the randomized phase IV PADMA studyM Schmidt, M Thill, J Rey, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Australian Health Review : a Publication of the Australian Hospital Association|August 11, 2001
From efficacy to effectiveness: managing organisational change to improve health services for young people with deliberate self harm behaviourM J Tobin, A R Clarke, R Buss, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 25, 2006
Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALSThomas W Gould, Robert R Buss, Sharon Vinsant, et al.
American Journal of Physiology. Cell Physiology|January 21, 2011
Small GTPase Rab11b regulates degradation of surface membrane L-type Cav1.2 channelsJabe M Best, Jason D Foell, Courtney R Buss, et al.
Genetics|March 17, 2004
Recombination within a nucleotide-binding-site/leucine-rich-repeat gene cluster produces new variants conditioning resistance to soybean mosaic virus in soybeansA J Hayes, S C Jeong, M A Gore, et al.
Crop Science|January 5, 2002
Genetic and Sequence Analysis of Markers Tightly Linked to the Soybean mosaic virus Resistance Gene, Rsv3S. C. Jeong, S. Kristipati, A. J. Hayes, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 29, 2006
Neuromuscular development in the absence of programmed cell death: phenotypic alteration of motoneurons and muscleRobert R Buss, Thomas W Gould, Jianjun Ma, et al.
ESMO Open|June 11, 2026
First-line ET plus palbociclib versus standard mono-chemotherapy in high-risk HR-positive/HER2-negative metastatic breast cancer and indication for chemotherapy: primary results from the randomized phase IV PADMA studyM Schmidt, M Thill, J Rey, et al.
Pageof 7